Betanoid Syrup 0,60 mg /5 ml Syrup
PDF Leaflet Revision Date: 4 April 2024
Clinical Summary
Quick overview from the medicine insert
Indication
Symptomatic treatment of inflammatory conditions where a steroid is indicated.
Dosage (summary)
0.6 mg to 4.8 mg daily in divided doses; can be given once daily.
Special Populations
- Elderly
- Diabetic patients
- Children
Pregnancy & Breastfeeding
Safety during pregnancy and breastfeeding not established; may affect fetal development.
Key Drug Interactions
- Anticholinesterases in myasthenia gravis
- Hepatic enzyme inducers
- Hypoglycaemic medicines
Contraindications
- Hypersensitivity to betamethasone
- Systemic fungal infections
- Peptic ulceration
Common side effects
- Increased susceptibility to infections
- Cushing's syndrome
- Hypokalaemia
Counselling Points
- Take with food to reduce GI upset
- Avoid exposure to infections
- Monitor for mood changes
Serious warnings
- Risk of myocardial rupture post-MI
- Adrenal suppression with prolonged use
- Psychiatric disturbances
Important Disclaimer
The Betanoid Syrup 0,60 mg /5 ml Syrup professional information leaflet below is the property of Pharmacare Limited and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
